Literature DB >> 2416624

Phenotype modulation in primary cultures of arterial smooth-muscle cells: reorganization of the cytoskeleton and activation of synthetic activities.

L Palmberg, M Sjölund, J Thyberg.   

Abstract

During primary culture, arterial smooth-muscle cells (SMCs) undergo transition from a contractile to a synthetic phenotype. As a consequence, they lose the ability to contract and, instead, acquire the ability to synthesize DNA, divide and produce extracellular-matrix components. In the present study, we used cytochemical and electron-microscopic methods to study the organization of the cytoskeleton in primary cultures of adult rat and human arterial SMCs. Freshly isolated cells were all in contractile phenotype and stained intensely with NBD-phallacidin, a fluorescent marker for F-actin. Diffuse, positive staining was also obtained using indirect-immunofluorescence microscopy with antibodies against tubulin and vimentin, which are subunit proteins of microtubules and intermediate filaments, respectively. Fine structurally, the cytoplasm of these cells was mainly filled with microfilament bundles coalescing in dense bodies. After a few hours in culture, the SMCs attached to the substrate and started to extend processes in various directions. These stained with antibodies to tubulin and vimentin, but not with NBD-phallacidin. Within 1-3 days of culture, the cells spread out on the substrate and developed a system of actin-containing stress fibre bundles spanning their entire length, as well as a radiating system of microtubules and vimentin filaments, originating in the juxtanuclear region. Fine structurally, these changes corresponded to a marked decrease in the number of microfilaments, an increase in the number of microtubules and intermediate filaments, and the formation of an extensive rough endoplasmic reticulum and a large Golgi complex. The morphological transformation of the cells was accompanied by the coordinated activation of DNA, RNA and protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416624     DOI: 10.1111/j.1432-0436.1985.tb00327.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

1.  TGF-beta 1 reverses PDGF-stimulated migration of human aortic smooth muscle cells in vitro.

Authors:  L Engel; U Ryan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

2.  Uterine smooth muscle cells in primary culture. Alterations in fine structure, cytoskeletal organization and growth characteristics.

Authors:  L Palmberg; J Thyberg
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress.

Authors:  Joshua K Salabei; Timothy D Cummins; Mahavir Singh; Steven P Jones; Aruni Bhatnagar; Bradford G Hill
Journal:  Biochem J       Date:  2013-05-01       Impact factor: 3.857

4.  Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.

Authors:  Guy Lahat; Quan-Sheng Zhu; Kai-Lieh Huang; Suizhao Wang; Svetlana Bolshakov; Jeffery Liu; Keila Torres; Robert R Langley; Alexander J Lazar; Mien Chie Hung; Dina Lev
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

Review 5.  Implications of autophagy for vascular smooth muscle cell function and plasticity.

Authors:  Joshua K Salabei; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2013-08-09       Impact factor: 7.376

6.  Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner.

Authors:  M Sjölund; U Hedin; T Sejersen; C H Heldin; J Thyberg
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

7.  Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells.

Authors:  U Hedin; B A Bottger; E Forsberg; S Johansson; J Thyberg
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.